TY - JOUR
T1 - A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures
AU - Kuhn, Richard J.
AU - Barrett, Alan D.T.
AU - Desilva, Aravinda M.
AU - Harris, Eva
AU - Kramer, Laura D.
AU - Montgomery, Ruth R.
AU - Pierson, Theodore C.
AU - Sette, Alessandro
AU - Diamond, Michael S.
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.
PY - 2023/10/15
Y1 - 2023/10/15
N2 - Flaviviruses are a genus within the Flaviviridae family of positive-strand RNA viruses and are transmitted principally through mosquito and tick vectors. These viruses are responsible for hundreds of millions of human infections worldwide per year that result in a range of illnesses from self-limiting febrile syndromes to severe neurotropic and viscerotropic diseases and, in some cases, death. A vaccine against the prototype flavivirus, yellow fever virus, has been deployed for 85 years and is highly effective. While vaccines against some medically important flaviviruses are available, others have proven challenging to develop. The emergence and spread of flaviviruses, including dengue virus and Zika virus, demonstrate their pandemic potential. This review highlights the gaps in knowledge that need to be addressed to allow for the rapid development of vaccines against emerging flaviviruses in the future.
AB - Flaviviruses are a genus within the Flaviviridae family of positive-strand RNA viruses and are transmitted principally through mosquito and tick vectors. These viruses are responsible for hundreds of millions of human infections worldwide per year that result in a range of illnesses from self-limiting febrile syndromes to severe neurotropic and viscerotropic diseases and, in some cases, death. A vaccine against the prototype flavivirus, yellow fever virus, has been deployed for 85 years and is highly effective. While vaccines against some medically important flaviviruses are available, others have proven challenging to develop. The emergence and spread of flaviviruses, including dengue virus and Zika virus, demonstrate their pandemic potential. This review highlights the gaps in knowledge that need to be addressed to allow for the rapid development of vaccines against emerging flaviviruses in the future.
KW - antibody neutralization
KW - antibody-dependent enhancement
KW - arbovirus
KW - dynamics
KW - flavivirus
KW - interferon
KW - vaccine
KW - virus-host interaction
UR - http://www.scopus.com/inward/record.url?scp=85174748679&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiad193
DO - 10.1093/infdis/jiad193
M3 - Article
C2 - 37849402
AN - SCOPUS:85174748679
SN - 0022-1899
VL - 228
SP - S398-S413
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
ER -